Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions (Q36619898)

15 August 2017

Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions (English)

1 reference

15 August 2017

Miédougé M

1

1 reference

15 August 2017

Rouzaud P

2

1 reference

15 August 2017

Salama G

3

1 reference

15 August 2017

Pujazon MC

4

1 reference

15 August 2017

Vincent C

5

1 reference

15 August 2017

Mauduyt MA

6

1 reference

15 August 2017

Reyre J

7

1 reference

15 August 2017

Carles P

8

1 reference

15 August 2017

Serre G

9

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

81

1 reference

15 August 2017

6

1 reference

15 August 2017

1059-1065

1 reference

Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Cytokeratin-19 fragment (CYFRA 21-1) in bladder cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Neurone-specific enolase levels in pleural effusions in patients with rheumatoid arthritis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Metastases of unknown primary site

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Thoracoscopy: present diagnostic and therapeutic indications.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

CA 72-4 serum marker--a new tool in the management of carcinoma patients.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Diagnosis and management of malignant pleural effusions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Continuing increase in mesothelioma mortality in Britain.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

The Diagnostic and Therapeutic Utility of Thoracoscopy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Clinical tumour markers in lung cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Clinical Characteristics of the Patient with Nonspecific Pleuritis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

State of the art. The pleura

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

The prognostic importance of tumor markers in adenocarcinomas of the gastrointestinal tract

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Pleural fluid neuron-specific enolase. A useful diagnostic marker for small cell lung cancer pleurisy.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Immunophenotyping of Mesothelial Cells and Carcinoma Cells With Monoclonal Antibodies to Cytokeratins, Vimentin, Cea and Ema Improves the Cytodiagnosis of Serous Effusions

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Carcinoembryonic Antigen Levels in Benign and Malignant Pleural Effusions

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Prostatic adenocarcinoma diagnosed by prostate-specific antigen analysis of pleural fluid

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362942

Cyfra 21-1. A new potential tumor marker for squamous cell carcinoma of head and neck

20 September 2018

1 reference

12 December 2020

Simultaneous enzyme immunoassay of carcinoembryonic antigen in pleural effusion and serum

1 reference

12 December 2020

Clinical evaluation of CYFRA 21-1 in malignant pleural fluids

1 reference

12 December 2020

Tumor markers cancer antigen 15.3, carcinoembryonic antigen, and tissue polypeptide antigen for monitoring metastatic breast cancer during first-line chemotherapy and follow-up

1 reference

12 December 2020

Evaluation of CYFRA 21-1 in malignant and benign pleural effusions

1 reference

12 December 2020

Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients

1 reference

12 December 2020

Carcinoembryonic antigen, tissue polypeptide antigen and neuron-specific enolase pleural levels used to classify small-cell and non-small-cell lung cancer patients by discriminant analysis

1 reference

12 December 2020

Evolution of Idiopathic Pleural Effusion

1 reference

12 December 2020

Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125

1 reference

12 December 2020

CEA, CA 15-3 and CYFRA 21-1 in serum and pleural fluid of patients with pleural effusions

1 reference

12 December 2020

Elevated level of carcinoembryonic antigen in nonmalignant pleural effusions

1 reference

12 December 2020

Prognostic significance of preimmunotherapy serum CA27.29 (MUC-1) mucin level after active specific immunotherapy of metastatic adenocarcinoma patients

1 reference

12 December 2020

Tumor markers in the diagnosis of malignant serous effusions

1 reference

12 December 2020

Cancer of the uterine cervix: sensitivity and specificity of serum Cyfra 21.1 determinations

1 reference

12 December 2020

False-positive results of carcinoembryonic antigen in pleural effusions

1 reference

12 December 2020

Ca 72-4 radioimmunoassay in the diagnosis of malignant effusions. Comparison of various tumor markers

1 reference

12 December 2020

Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer

1 reference

12 December 2020

Improvement of the diagnosis of the cause of pleural effusion in patients with lung cancer by simultaneous quantification of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) pleural levels

1 reference

12 December 2020

Value of serum and effusion fluid CEA levels for distinguishing between diffuse malignant mesothelioma and carcinomatous pleural metastases

1 reference

12 December 2020

Carcinoembryonic antigen in pleural effusions: A diagnostic and prognostic indicator

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6690807

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

10576665

1 reference